7th CPC Symposium Video
Started in 2010, the CPC symposium has now become an annual scientific event that brings together scientific leaders in the peptide-based therapeutics from biopharmaceutical industries and academia. This year, “The 7th CPC Symposium on Peptide Therapeutics” will continue the tradition of the successful conferences from previous years. The meeting will offer a forum for scientific discussions of recent developments in the exciting field of peptide therapeutics. It will feature lectures on a broad range of topics including new technologies, drug discovery, CMC, and clinical developments.
Rocklin Facility Construction Update: Advancing U.S.-Based Peptide API Manufacturing
Rocklin Facility Construction Update: Advancing U.S.-Based Peptide API Manufacturing
CPC Scientific’s Rocklin facility is undergoing a major expansion to establish a 41,000 sq ft Center of Excellence for U.S.-based peptide API manufacturing. Construction is now underway—more updates coming soon.
Medtide Inc., CPC Scientific’s Parent Company, Debuts on Hong Kong Stock Exchange
Medtide Inc., CPC Scientific’s Parent Company, Debuts on Hong Kong Stock Exchange
Join us as we celebrate a proud milestone: the successful listing of Medtide Inc., parent company of CPC Scientific, on the main board of the Hong Kong Stock Exchange in June 2025. This moment marks a new chapter of growth, innovation, and global impact for our organization.
Green Approaches to Peptide & Peptide–Oligo Conjugate Manufacturing
Green Approaches to Peptide & Peptide–Oligo Conjugate Manufacturing
Sheri Ambriz, MBA took the stage at TIDES USA 2025 in San Diego, CA, to share insights on green approaches to peptide and peptide–oligonucleotide conjugate manufacturing.
